Founder

Kemp Dolliver, CFA

Cherrystone Hill Research

Equity Capital Markets

<p>Jacobson Pharmaceutical Corporation Limited is a pending listing on the HKEX. This Insight forks <a href="https://www.smartkarma.com/profiles/673" target="_blank" data-smartkarma-citation="accounts:673">Toh Zhen Zhou</a> 's Insight <a href="https://www.smartkarma.com/insights/jacobson-pharma-ipo-growth-is-contingent-on-acquisitions" target="_blank" data-smartkarma-citation="insights:5761">Jacobson Pharma IPO - Growth Is Contingent on Acquisitions</a> that discusses the company using Smartkarma’s IPO framework. This Insight provides some incremental context around the company’s business, strategy, and risks. We address many of the same points as Toh Zhen Zhou, but have a different view on the details. </p><p>We like the business and view the offering favorably based on our analysis of the business and the proposed valuation. We should caveat that we have neither seen a pre-deal report nor attended a roadshow meeting.</p>

Jacobson Pharmaceutical Corporation Limited is a pending listing on the HKEX. This Insight forks Toh Zhen Zhou 's Insight Jacobson Pharma IPO - Growth Is Contingent on Acquisitions that discusses the company using Smartkarma’s IPO framework. This Insight provides some incremental context around the company’s business, strategy, and risks. We address many of the same points as Toh Zhen Zhou, but have a different view on the details. We like the business and view the offering favorably based on our analysis of the business and the proposed valuation. We should caveat that we have neither seen a pre-deal report nor attended a roadshow meeting.

Jacobson Pharma IPO -- Home Team Advantage